Ähnliche Einträge

• Health-related quality of life in multiple myeloma patients treated with high- or low-dose lenalidomide maintenance therapy after autologous stem cell transplantation: results from the LenaMain trial (NCT00891384)
  von: Boquoi, Amelie, et al.
  Veröffentlicht: (2023)
• Immunosuppressive therapy for patients with myelodysplastic syndrome: a prospective randomized multicenter phase III trial comparing antithymocyte globulin plus cyclosporine with best supportive care—SAKK 33/99
  von: Passweg, Jakob R., et al.
  Veröffentlicht: (2011)
• Non-curative therapies and their impact on the prognosis of patients with myelodysplastic syndromes: a retrospective matched-pairs analysis
  von: Rauhe, Katharina Anna, et al.
  Veröffentlicht: (2025)
• Identification of gene expression-based prognostic markers in the hematopoietic stem cells of patients with myelodysplastic syndromes
  von: Pellagatti, Andrea, et al.
  Veröffentlicht: (2013)
• Efficacy and tolerability of high- versus low-dose lenalidomide maintenance therapy of multiple myeloma after autologous blood stem cell transplantation
  von: Fenk, Roland, et al.
  Veröffentlicht: (2020)